Posts by tag
CancerWorld
From Dalian to Houston and Back to Yemen: Bridging the Global Oncology Divide
A Global Summit, a Personal Reckoning At the European Society for Medical Oncology (ESMO) Leadership Summit in Singapore, discussions moved rapidly from antibody–drug conjugates to next-generation sequencing and the expanding role of immunotherapy. Clinical trial curves filled large screens, and…
The Day Immunotherapy Went Off-Patent
In oncology, some milestones arrive with applause. Others arrive quietly. This year, one of the most important cancer drugs of the modern era begins to lose its monopoly. Nivolumab, one of the first PD-1 inhibitors to reach patients, is set…
Leading with Listening: Why Isabel Rubio Believes Europe’s Cancer Future Depends on Trust, Equity, and Political Courage
Leadership in oncology is often measured in breakthroughs, budgets, and policy frameworks. But for Dr. Isabel Rubio, President of the European Cancer Organisation (ECO), leadership begins somewhere far more intimate: in listening. “Progress happens only when expertise is matched by…
Bente Mikkelsen: “Success is Something We Build Together”
From the bedside to global reform, and why equity must be engineered, not hoped for “I think I chose medicine because it gave all the opportunities to address people, both at a national level, but also internationally. And it’s a…
Karen Knudsen: The Scientist Who Refused to Move Slowly
“I’m a scientist first and foremost. I don’t remember a time not thinking about being a scientist.” What Karen Knudsen, the CEO of Parker Institute for Cancer Immunotherapy, remembers clearly is the pull not toward prestige or power, but toward…
CancerWorld #113 (March 2026)
Scientific discovery drives oncology forward, but progress only truly begins when knowledge is turned into action. Every issue of CancerWorld explores the people, ideas, and systems shaping the future of oncology. Scientific breakthroughs remain essential, but their true value emerges…
“United by Unique” – Does it Really Make a Difference, or is it Just a Cliché?
“Nobody realizes that some people expend tremendous energy merely to be normal.”— Albert Camus People at the Centre of Care “United by Unique” is the World Cancer Day theme for 2025–2027. This year, the focus is on placing people at the…
Making Sense of a Decade of Progress in Advanced Breast Cancer: ABC8, Lisbon 2025
The 8th ABC International Consensus Conference (ABC8), Lisbon 2025 Over the past decade, the landscape of advanced breast cancer has changed more rapidly than at any time since systemic therapy became standard. New drug classes, more refined biomarkers, and increasingly…
Europe’s National Cancer Mission Hubs: From a Vision to Sustainable Infrastructures
European cancer policy has entered a decisive phase. After years of strategy-building, consultation, and pilot projects, the question facing policymakers is no longer whether Europe has the right ambitions, but whether it can turn those ambitions into sustainable systems that…
Rethinking Immunotherapy for Pancreatic Cancer: A Universal Approach
Chimeric antigen receptor natural killer T (CAR-NKT) cell therapy, a novel form of immunotherapy, is emerging as a promising ‘off-the-shelf’ treatment for patients with pancreatic cancer. In a study published in PNAS, November 21, 2025, U.S. investigators report that CAR-NKT cells…